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Abstract
Background: Despite the high rates and regional variation of esophageal squamous cell carcinoma (ESCC) in East
Africa, the contributions of smoking and alcohol to the ESCC burden in the general population are unknown.
Methods: We conducted a case-control study of patients presenting for upper gastrointestinal endoscopic
examination at Mbarara Regional Referral Hospital, Uganda. Sociodemographic data including smoking and
alcohol intake were collected prior to endoscopy. Cases were those with histological diagnosis of ESCC and
controls were participants with normal endoscopic examination and gastritis/duodentitis or normal histology.
We used odds ratios associated with ESCC risk to determine the population attributable fractions for smoking,
alcohol use, and a combination of smoking and alcohol use among adults aged 30 years or greater who
underwent upper gastrointestinal endoscopy.
Results: Our study consisted of 67 cases and 142 controls. Median age was 51 years (IQR 40–64); and participants
were predominantly male (59 %). Dysphagia and/or odynophagia as indications for endoscopy were significantly more
in cases compared to controls (72 % vs 6 %, p < 0.0001). Male gender and increasing age were statistically associated
with ESCC. In the unadjusted models, the population attributable fraction of ESCC due to male gender was 55 %,
female gender - 49 %, smoking 20 %, alcohol 9 % and a combination of alcohol & smoking 15 %. After adjusting for
gender and age, the population attributable fraction of ESCC due to smoking, alcohol intake and a combination of
alcohol & smoking were 16, 10, and 13 % respectively.
Conclusion: In this population, 13 % of esophageal squamous cell carcinoma cases would be avoided if smoking and
alcohol use were discontinued. These results suggest that other important risk factors for ESCC in southwestern
Uganda remain unknown.
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Background
Esophageal squamous cell carcinoma is lethal, with a poor
5-year survival even in resource rich settings [1, 2]. In
sub-Saharan Africa, the incidence of esophageal squa-
mous cell carcinoma (ESCC) has regional variation
with southern and eastern regions reporting signifi-
cantly higher incidence rates [3]. It is postulated that
differences in risk factor profiles may explain these re-
gional variations. Therefore, public health approaches
for risk factor modification and early screening
methods for curable lesions offer a great opportunity
to reduce ESCC morbidity and mortality.
Though alcohol use and smoking are known risk fac-
tors for ESCC [4], existing data are inconclusive in link-
ing various factors to an increased risk of ESCC
including: human papilloma virus [5, 6], consumption of
hot drinks [7], diets low in fruit and vegetables [8], and
exposure to nitrosamines [9, 10], suggesting that these
* Correspondence: okello.samson@must.ac.ug
1Department of Internal Medicine, Mbarara University of Science and
Technology, P. O Box 1410 Mbarara, Uganda
2Department of Epidemiology, Harvard T.H Chan School of Public Health,
Boston, MA, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Okello et al. BMC Cancer  (2016) 16:446 
DOI 10.1186/s12885-016-2492-x
environmental risk factors alone may not be responsible
for ESCC.
Though alcohol and tobacco are thought to synergis-
tically interact for the development of esophageal squa-
mous cell carcinoma [11], data are lacking in the
characterizations of the impact of these risk factors on
the incidence of ESCC using population attributable
fractions (PAFs). PAFs account both for the strength of
the association and the prevalence of the risk factor.
Studies in ESCC among low and high risk populations
report between 60 and 75 % population attributable frac-
tions for ESCC due to smoking and alcohol [12–15] but
PAFs for Africa have not been previously reported. We
aimed to determine the population attributable fraction for
smoking and alcohol use for ESCC risk in an ESCC high
incidence African population in southwestern Uganda.
Methods
Study participants and procedures
We carried out a case control study using data from all
patients, aged 30 years or greater, who presented for
upper gastrointestinal endoscopy from January 2003 to
December 2014 at the Mbarara Regional Referral
Hospital (MRRH), southwestern Uganda. Our endoscopy
service was nonfunctional during 2010 to 2012. However,
our center is the only endoscopy service in southwestern
Uganda; receiving referrals from within MRRH and other
health facilities; private and public in southwestern
Uganda with an estimated population of 8.7 million
people [16].
Before performing upper GI endoscopy, a trained
nurse administered a standardized questionnaire to col-
lect data including age, gender, history of alcohol and
smoking, and symptoms after provision of informed
consent for endoscopy & biopsy.
A nurse sprayed 5 mL of 1 % lidocaine into the pa-
tients’ mouth for 5 min; intravenous medications diaze-
pam 5 mg and fentanyl 50 μg were then administered
for sedation. With the patients positioned in the left lat-
eral position, a trained endoscopist then inserted a
gastroscope visually examining the entire esophagus and
stomach. Tissue biopsies of both abnormal and occa-
sionally normal mucosae were picked from unstained
foci with the number of biopsies taken depended on the
size of the lesion but minimum of three biopsies. Some
pieces of tissue biopsy were used to perform rapid ure-
ase (CLO) test while the remaining biopsies were kept in
10 % buffered formalin before transportation to the
histopathology laboratory at the department of Path-
ology, Mbarara University of Science and Technology
(MUST) for histopathology microscopic examination.
At the MUST histopathology laboratory, all esophageal
biopsies were processed into sections, stained with
hematoxylin and eosin for 1 h, and then examined using
standard diagnostic criteria for microscopic atypia. Spe-
cifically, for esophageal squamous cell carcinoma, path-
ologist reported features such as presence of nuclear
atypia, prominent keratinization and evidence of inva-
sion [17].
Data collection
We reviewed participants’ records, first extracting cases of
esophageal squamous cell carcinoma and then consecu-
tively sampling for controls. For all participants, we col-
lected pre-endoscopic data including age, sex, history of
alcohol and smoking, and presenting symptoms. We also
reviewed diagnostic upper gastrointestinal endoscopy re-
ports to collect information pertaining to the site of suspi-
cious esophageal lesions i.e., upper third (15–24 cm),
middle third (24–32 cm), and lower third (32–40 cm)
esophageal lesions [18]. All data were doubly entered into
an electronic database and crosschecked to minimize
entry and transcription errors.
Ascertainment of cases and controls
We defined a case as any participant having histological
diagnosis of esophageal squamous cell carcinoma either
differentiated or undifferentiated. Controls were partici-
pants with normal endoscopic examination or gastritis/
duodentitis or normal histology. We excluded from this
analysis participants with histological diagnoses of other
esophageal abnormalities such as esophageal dysplasia,
esophageal hyperplasia, esophagitis, esophageal adeno-
carcinoma, Barrett’s esophagus or gastric cancer, peptic
ulcer disease or missing histology results.
Statistical analysis
We described baseline characteristics of cases and con-
trols using summary statistics.
Associations between exposure variables: sex, age at
presentation, history of smoking and alcohol with
esophageal squamous cell carcinoma were estimated in
unadjusted and multivariate logistic regression models
expressed as odds ratios with 95 % confidence intervals.
Exposure variables smoking and drinking alcohol were
treated as binary (never, reference group; ever, risk
group). Only variables that provided odds ratios (ORs)
for ESCC with p-values < 0.1 in the univariate logistic re-
gression model were included in the multivariate logistic
regression model.
Because the main objective of this analysis was to in-
vestigate the population attributable fraction of Esopha-
geal squamous cell carcinoma due to smoking and
alcohol, we assumed that smoking and drinking alcohol
individually exert effects on ESCC risk and that these
interact thus, we introduced a joint category of smoking
and alcohol using an interaction term [19]. We used
crude odds ratio estimates from the univariate logistic
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regression and the adjusted odds ratios controlling for
gender and age to determine the unadjusted and ad-
justed population attributable fractions (PAF) for smok-
ing, alcohol use, and a combination of smoking and
alcohol use. We used crude odds ratio estimates from
the univariate logistic regression and the adjusted odds
ratios controlling for gender and age to determine the
unadjusted and adjusted population attributable frac-
tions (PAF) for smoking, alcohol use, and a combination
of smoking and alcohol use respectively. This was calcu-
lated using the punafcc package available in STATA soft-
ware. The PAFs and 95 % confidence intervals were
estimated by a method that is based on unconditional
logistic regression [20], which provides adjusted PAF es-
timates by combining adjusted odds ratio estimates and
the observed prevalence of the risk factors among case
patients.
All statistical tests were two-sided. All analyses were
performed with STATA version 13 (Stata Corporation,
College Station, Texas, USA).
Results
Among 913 endoscopes performed at Mbarara Regional
Referral Hospital between 2003 and 2014, there were 67
(7.34 %) new cases of esophageal squamous cell carcin-
oma. We excluded 428 (46.88 %) with missing histology
results, 53 (5.81 %) with inadequate biopsies (no histo-
logical diagnosis could be made), and 148 with other
histology results of esophagitis, esophageal adenocarcin-
oma, Barrett’s esophagus, esophageal Kaposi sarcoma,
and gastric malignancies.
Among the 142 controls, 30 (21.13 %) had normal
histology and 45 (31.69 %) had gastritis/duodentitis.
There were a higher proportion of males among cases
compared to controls (79.10 % vs 52.82 %). The age dis-
tribution was similar among cases and controls except
for < 41 years with a higher proportion of controls
(Table 1).
As expected, indication for endoscopy were signifi-
cantly different between cases and controls, for example,
dysphagia and/or odynophagia were significantly more
frequent endoscopic indications in cases compared to
controls (72.29 % vs 5.56 %, p < 0.0001) (Table 2). Over-
all, the common sites for esophageal masses were the
lower and mid portions of the esophagus in 28 (41.79 %)
and 21 (31.34 %) respectively. Self-reported HIV infec-
tion rates were similar between these groups.
In the univariate logistic regression modeling, we found;
increasing age, male gender, alcohol & smoking as factors
associated with a diagnosis of ESCC. In the multivariate
logistic regression analysis (Table 3), we found male
gender (AOR 3.65, 95 % CI (1.67 – 7.98), p = 0.001), age
group of 41 to 50 years (AOR 12.95, 95 % CI (2.57 – 65.10),
p = 0.002); 51 – 60 year (AOR 6.50, 95 % CI (1.32 – 31.90),
Table 1 Baseline characteristics of cases and controls
Characteristic Control Case
n = 142, n (%) n = 67, n (%)
Male gender 75 (52.82) 53 (79.10)
Age group, years
31–40 29 (20.42) 2 (2.99)
41–50 28 (19.72) 19 (28.36)
51–60 32 (22.54) 16 (23.88)
61–70 27 (19.01) 16 (23.88)
>70 22 (15.49) 11 (16.42)
Missing 4 (2.82) 3 (4.48)
Substance abuse
Smoking 8 (5.63) 6 (8.96)
Alcohol 22 (15.49) 6 (8.96)
Alcohol & smoking 10 (7.04) 14 (20.90)
Presenting symptoms
Dyspepsia 77 (54.23) _
Dysphagia 14 (9.86) 38 (56.72)
Dysphagia & weightloss 4 (2.82) 6 (8.96)
Regurgitationb 8 (5.63) 1 (1.49)
Odynophagia 4 (2.82) 8 (11.94)
Upper GI bleedinga 16 (11.27) _
Othersc 18 (12.68) 6 (8.96)
Dysphagia & Odynophagia 1 (0.70) 8 (11.94)
HIV positive 2 (1.41) 2 (2.99)
Upper GI bleedinga:hematemesis and/or melena; Regurgitationb: Epigastric
pain, heartburn, and/or regurgitation Othersc:vomiting, abdominal pain, and
chest pain
Table 2 Endoscopic examination features of cases and controls
Endoscopic features Control Case
n = 142, n (%) n = 67, n (%)
Normal 30 (21.13) _
Upper esophageal mass _ 5 (7.46)
Mid esophageal mass 1 (0.70) 6 (8.96)
Lower esophageal mass 8 (5.63) 21 (31.34)
Esophageal mass (unspecified location) 2 (1.41) 28 (41.79)
GE junctional mass 4 (2.82) 2 (2.99)
Gastritis 45 (31.69) 1 (0.49)
Othersa 83 (58.45) 2 (2.99)
Missing 14 (9.86) 2 (2.99)
Rapid urease (CLO) positivity 42 (29.58) 9 (13.43)
Othersa: gastritis of unspecified location; CLO: Campylobacter like organism
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p = 0.021); 61 – 70 year (AOR 7.26, 95 % CI (1.45 – 36.41),
p = 0.016); and age > 70 year (AOR 5.23, 95 % CI (0.99 –
27.69), p = 0.052) were independently correlated with
esophageal squamous cell carcinoma. Self-reported use of
alcohol and smoking were not statistically associated with
ESCC (Table 3).
To estimate the population attributable fraction of ESCC
due to smoking and alcohol, age data was used as continu-
ous (modeling decision taken based on the -2Log likeli-
hood). In the unadjusted models, the population
attributable fraction of ESCC due to male gender was
55.36 %, 95 % CI (26.46 – 72.90), female gender
was −48.71 %, 95 % CI ( −81.33 – −21.97), and alcohol &
smoking was 14.90 %, 95 % CI (2.95 – 25.38). After adjust-
ing for age and gender, the population attributable fraction
of ESCC due to a combination of alcohol & smoking was
12.66 %, 95 % CI (−1.29 – 24.61) (Table 4).
Discussion
This is the first study to report PAFs for ESCC risk
factors smoking and alcohol in an ESCC high-risk region
in sub-Saharan Africa. Our study describes a low popu-
lation attributable fraction of esophageal squamous cell
carcinoma due to smoking and alcohol use in southwest-
ern Uganda i.e., if smoking and alcohol use were elimi-
nated in the rural population of southwestern Uganda,
approximately 13 % of new esophageal squamous cell
carcinoma cases could be avoided. This is lower than an
estimated two-thirds and three-fourths population at-
tributable fractions of ESCC for smoking and alcohol re-
spectively, from priorstudies in high - risk and low - risk
populations [12–15]. However, our results corroborate
findings from one of the ESCC highest risk areas of
northern China (Linxian County) where it has been sug-
gested that alcohol and tobacco consumption are not
the major risk factors for ESCC [21]. We posit that
ESCC in this population results from multifactorial in-
teractions of environmental factors, diet, and genetics
[22–24] and not individual factors (alcohol and smoking)
only.
The PAFs stratified by gender indicated that a
higher percentage of ESCC would be prevented by
change in gender which confirms that male gender
confers a higher risk of ESCC as described by other
Table 3 Univariate and multivariate logistic regression models evaluating risk factors for esophageal squamous cell carcinoma in
Southwestern Uganda
Characteristic Univariate Model OR (95 % CI) p-value Multivariate Model Adjusted OR (95 % CI) p-value
Female gender REF REF
Male gender 3.33 (1.69 – 6.55) 0.0001 3.65 (1.67 – 7.98) 0.001
Age category
31 – 40 REF REF
41 – 50 9.84 (2.09 – 46.21) 0.004 12.95 (2.57 – 65.10) 0.002
51 – 60 7.25 (1.53 – 34.28) 0.012 6.50 (1.32 – 31.90) 0.021
61 – 70 8.59 (1.80 – 40.92) 0.007 7.26 (1.45 – 36.41) 0.016
> 70 7.25 (1.46 – 36.10) 0.016 5.23 (0.99 – 27.69) 0.052
Substance usea
Never smoke and alcohol REF REF
Smoking 2.93 (1.43 – 5.71) 0.003 1.38 (0.41 – 4.67) 0.600
Alcohol 1.46 (0.76 – 2.82) 0.255 0.91 (0.32 – 2.64) 0.864
Alcohol & smoking 3.49 (1.46 – 8.34) 0.005 1.93 (0.32 – 11.42) 0.471
Rapid urease test positivity 0.23 (0.05 – 0.97) 0.046 - -
HIV infection 3.68 (0.49 – 27.64) 0.205 - -
Substance usea: self-reported current or former use
Table 4 Unajusted and adjusted population attributable
fraction of esophageal squamous cell carcinoma due to gender,
individual and combined effects of smoking and alcohol in
Southwestern Uganda
Characteristic Crude PAF model aAdjusted PAF model
% PAF (95 % CI) % PAF (95 % CI)
Male 55.36 % (26.46 – 72.90) -





Smoking 19.67 % (4.91 – 32.14) 15.62 % (−2.49 – 30.53)
Alcohol 9.04 % (−8.42 – 24.36) 10.17 % (−9.12 – 26.05)
Alcohol &
smoking
14.90 % (2.95 – 25.38) 12.66 % (−1.29 – 24.61).
aAdjusted for age and gender
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studies [25, 26] presumably due to the high exposure
to smoking and alcohol [26] or hormonal differences
[27, 28]. In fact, the PAFs of smoking and alcohol as
individual factors indicated that smoking had the
highest PAF for ESCC in the unadjusted (19.7 %) as
well as in the gender and age adjusted analyses
(15.6 %). The PAF estimates for alcohol use were
lowest even when compared with the PAF of the
combined term of smoking and alcohol. This finding
emphasizes that smoking (and less so alcohol use) is
more prevalent in endemic regions translating into a
high attributable fraction. Therefore, other factors
including genetic variations, socioeconomic dispar-
ities, dietary factors, and possibly infectious causes,
are may contribute to the population attributable
fraction differences in this population [29].
Our study highlights ESCC occurring in younger age
(<60 years) despite the global trends that esophageal
squamous cell cancer is known to occur in the late 6th
and 7th decades of life [30] and cases occurring before
the age of 40 years are rare [31]. Within Uganda,
esophageal cancer has been described in older age
(>60 years) in central [32] and northern region [33].
However, our finding is similar to reports from south-
western Kenya, which showed a significant number of
esophageal cancer patients presenting at very young ages
[31, 34]. This supports our assertion of peculiar risk fac-
tors for ESCC that likely afflicts earlier in life such that
there is earlier presentation of disease at younger age.
Taken together, we posit that maybe there may be
unique carcinogenic risk factor(s) for ESCC leading to
early onset and/or radid progression.
This data should be interpreted in the context of the
study design. As patients studied were referred for en-
doscopy to a referral center, referral bias likely exists and
they may not accurately represent the general
population.
As with all non-randomized observational studies, our
study could suffer from unmeasured or residual con-
founding on the associations between younger age
(<40 years) and ESCC. However, since our results are
similar to findings in high-risk populations, such con-
founders are more likely to represent actual mediators of
the relationship between young age and ESCC, than true
confounder per se.
Conclusion
In this study, only 13 % of esophageal squamous cell car-
cinoma cases would be avoided if alcohol and smoking
were discontinued in a rural population of southwestern
Uganda, suggesting that important risk factors for
esophageal squamous cell carcinoma in this population
are not known. Future work should focus on relation-
ships between environmental, infections, diet, genetic,
and epigenetic factors as esophageal squamous cell
carcinoma risks in this population.
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